Actively Recruiting
Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Led by Jordan Collaborating Cardiology Group · Updated on 2025-11-28
200
Participants Needed
2
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
CONDITIONS
Official Title
Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients
- Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
- Antiplatelet medication (s) prescribed during index admission to hospital.
- Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
You will not qualify if you...
- Non cardiac chest pain.
- No administration of antiplatelet agents during hospitalization.
- Refusal of contact for follow up.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Jordan University Hospital
Amman, Jordan, 11180
Actively Recruiting
2
Istishari Hospital
Amman, Jordan, 11184
Not Yet Recruiting
Research Team
A
Ayman Hammoudeh, MD, FACC
CONTACT
L
Laith Habahbeh, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here